SCHEMBL2126160

SCHEMBL2126160

O=C1NC[CH]S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872865 0.72
SCHEMBL6739445 0.72
SCHEMBL12483162 0.63
SCHEMBL7086866 0.61
SCHEMBL1593092 0.60
SCHEMBL1035336 0.56
SCHEMBL586833 0.54
SCHEMBL5597052 0.54
SCHEMBL775329 0.48
Hydrochloric Acid SCHEMBL27779692 0.46 IDH1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061065-B1 Methods for producing cyclopropane carboxylates SUMITOMO CHEMICAL CO (JP) 2006-08-23 EP claimed
EP-1203760-B1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL CO (JP) 2005-04-13 EP claimed
US-6706910-B2 BY TRANSESTERIFICATION OF A CYCLOPROPANECARBOXYLATE AND A MONOHYDROXY COMPOUND IN THE PRESENCE OF A LITHIUM ALKOXIDE OR LITHIUM ARYLOXIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-03-16 US claimed
US-6531626-B1 Transesterification in the presence of a samarium alkoxide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-11 US claimed
EP-0992479-B1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL CO (JP) 2003-01-02 EP claimed
US-6441220-B1 ESTERIFICATION WITH ALCOHOL IN PRESENCE OF BASIC CATALYSTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-08-27 US claimed
EP-1203760-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-08 EP claimed
US-20020052525-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-02 US claimed
EP-1061065-A2 Methods for producing cyclopropane carboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-12-20 EP claimed
EP-0992479-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-04-12 EP claimed
US-20230233551-A1 COMPOSITIONS AND METHODS FOR TREATMENT CITIBANK, N.A., AS NOTES COLLATERAL AGENT 2023-07-27 US disclosed
US-20210338839-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY NOVARTIS AG (CH) 2021-11-04 US disclosed
EP-3797775-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY Novartis AG (CH) 2021-03-31 EP disclosed
US-10960087-B2 Compositions and methods for treatment of diabetic retinopathy NOVARTIS AG (CH) 2021-03-30 US disclosed
EP-3167886-B1 COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA NOVARTIS AG (CH) 2020-08-05 EP disclosed
WO-2002059114-A1 LFA-1 ANTAGONIST COMPOUNDS GENENTECH, INC. (US) 2002-08-01 WO disclosed
EP-1203760-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-08 EP disclosed
US-20020052525-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-02 US disclosed
EP-1061065-A2 Methods for producing cyclopropane carboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-12-20 EP disclosed
EP-0992479-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-04-12 EP disclosed